CrunchBase is hiring! Check out our open positions →
Register | Login or Login

General Information

Company Accera

Tags

Axona

Axona is a first-in-class medical food for the clinical dietary management of the metabolic processes associated with mild-to-moderate Alzheimer’s. Dispensed by prescription, it targets the metabolic deficiencies and imbalances associated with AD by providing an alternative energy source for brain cells.

Recent Milestones

  • Check
    Axona — Accera Launches Axonaâ„¢, First Medical Food Therapy to Help Manage Mild-to-Moderate Alzheimer’s Disease Broomfield, CO, March 2, 2009 – Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system (CNS) disease (3/2/09)
    Posted 7/7/09 at 3:23pm via accerapharma.com

Screenshots

Videos

Sources

    Accera Web site (accerapharma.com) [edit]
Edit This Page
Last Edited 7/8/09

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy